Overexpression of different MCT isoforms, herein focusing on MCT1, has launched several investigations aiming to correlate its inhibition with lower glucose consumption, lactate production, and an impairment in the aforementioned cancer aggressiveness features [4,6]. The gene discussed is SLC16A1; the disease is cancer.